PATENT CLAIM ANALYSIS

Application Number: 16128601
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "249000"]

Abstract:
The present invention relates to compositions and methods for controlling glycemia in a mammalian in need thereof. The present invention relates to compositions and methods for the treatment of diabetes and related disorders. More specifically, the present invention relates to novel therapies or combinatorial therapies for diabetes and related disorders, based on compositions controlling the blood glucose level.

Claim (Index 3):
The method of  claim 2 , comprising administering to said mammalian subject a composition comprising at least one of the following combinations of compounds:\n ifenprodil and acamprosate, ifenprodil and baclofen, ifenprodil and nicergoline, ifenprodil and torasemide, ifenprodil and triamterene, or ifenprodil and tolfenamic acid, or salt(s), prodrug(s), or sustained release formulation(s) thereof.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 97.0
- Lexical Diversity: 1.8
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15142227', '14698920', '14425926', '16025461', '14014650']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8612165133755344
- 35 USC 102 Novelty (BERT): 0.7653720667782107
- Combined Prediction Score: 0.851632068715802
- Mean Citation Score: 757.778456
- Max Citation Score: 1237.368
- Similarity Product: 924.2567853097916

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test